Ligand Pharmaceuticals Says On Sept 21, Co's Unit, CyDex Pharmaceuticals, Entered Into An Amendment To Supply Agreement With Gilead Sciences, Agreed To Supply Up To 150% Of Forecasted Amount Of Captisol; Co. Notes Captisol Is A Remdesivir Component